Members of the carcinoid and neuroendocrine tumor community are invited to be the first to hear the results of the Carcinoid Syndrome Impact Survey that was conducted this summer. A Webcast about the survey results will be presented on Wednesday, September 21, 2016 from 12 noon to 1:30 pm, Eastern Time. While there is no charge for the Webcast, registration is required. Please register today as space is limited: https://attendee.gotowebinar.com/register/5889072616569382658.
More than 500 patients and 150 physicians responded to help raise awareness of what it is like to live with carcinoid syndrome and the severity of the impact. Their responses will help improve discussions about treatment and inform solutions to patient care.
The Webcast will be broadcast live from New Orleans, where the 2016 National NET Cancer Patient Conference will be taking place. Lexicon Pharmaceuticals conducted the Carcinoid Syndrome Impact Survey in partnership with seven leading national and regional neuroendocrine tumor patient advocacy and patient groups:
- Carcinoid Cancer Foundation (CCF)
- Neuroendocrine Cancer Awareness Network (NCAN)
- Neuroendocrine Tumor Research Foundation (NETRF)
- Healing NET Foundation
- Los Angeles Carcinoid Neuroendocrine Tumor Society (LACNETS)
- NorCal CarciNET Community
- Big Apple NETs